HK1084403A1 - Conjugates of malarial pre-erythrocytic stage polypeptide molecules and lipids - Google Patents
Conjugates of malarial pre-erythrocytic stage polypeptide molecules and lipidsInfo
- Publication number
- HK1084403A1 HK1084403A1 HK06106687.9A HK06106687A HK1084403A1 HK 1084403 A1 HK1084403 A1 HK 1084403A1 HK 06106687 A HK06106687 A HK 06106687A HK 1084403 A1 HK1084403 A1 HK 1084403A1
- Authority
- HK
- Hong Kong
- Prior art keywords
- asn ile
- svdvngevke
- rdelfnelln
- nileesqvnd
- difnslvksv
- Prior art date
Links
- 229920001184 polypeptide Polymers 0.000 title abstract 3
- 108090000765 processed proteins & peptides Proteins 0.000 title abstract 3
- 102000004196 processed proteins & peptides Human genes 0.000 title abstract 3
- 150000002632 lipids Chemical class 0.000 title 1
- 150000001413 amino acids Chemical class 0.000 abstract 2
- XRMDCWJNPDVAFI-UHFFFAOYSA-N 2,2,6,6-tetramethyl-1-oxopiperidin-1-ium-4-ol Chemical compound CC1(C)CC(O)CC(C)(C)[N+]1=O XRMDCWJNPDVAFI-UHFFFAOYSA-N 0.000 abstract 1
- XVBDDUPJVQXDSI-PEFMBERDSA-N Asn-Ile-Glu Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CCC(=O)O)C(=O)O)NC(=O)[C@H](CC(=O)N)N XVBDDUPJVQXDSI-PEFMBERDSA-N 0.000 abstract 1
- AFODTOLGSZQDSL-PEFMBERDSA-N Glu-Asn-Ile Chemical compound CC[C@H](C)[C@@H](C(=O)O)NC(=O)[C@H](CC(=O)N)NC(=O)[C@H](CCC(=O)O)N AFODTOLGSZQDSL-PEFMBERDSA-N 0.000 abstract 1
- BFEZQZKEPRKKHV-SRVKXCTJSA-N Glu-Pro-Lys Chemical compound C1C[C@H](N(C1)C(=O)[C@H](CCC(=O)O)N)C(=O)N[C@@H](CCCCN)C(=O)O BFEZQZKEPRKKHV-SRVKXCTJSA-N 0.000 abstract 1
- NBJAAWYRLGCJOF-UGYAYLCHSA-N Ile-Asp-Asn Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CC(=O)N)C(=O)O)N NBJAAWYRLGCJOF-UGYAYLCHSA-N 0.000 abstract 1
- IAJFFZORSWOZPQ-SRVKXCTJSA-N Leu-Leu-Asn Chemical compound CC(C)C[C@H](N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(O)=O IAJFFZORSWOZPQ-SRVKXCTJSA-N 0.000 abstract 1
- RXGLHDWAZQECBI-SRVKXCTJSA-N Leu-Leu-Ser Chemical compound CC(C)C[C@H](N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(O)=O RXGLHDWAZQECBI-SRVKXCTJSA-N 0.000 abstract 1
- KOSRFJWDECSPRO-UHFFFAOYSA-N alpha-L-glutamyl-L-glutamic acid Natural products OC(=O)CCC(N)C(=O)NC(CCC(O)=O)C(O)=O KOSRFJWDECSPRO-UHFFFAOYSA-N 0.000 abstract 1
- 239000000427 antigen Substances 0.000 abstract 1
- 102000036639 antigens Human genes 0.000 abstract 1
- 108091007433 antigens Proteins 0.000 abstract 1
- 108010055341 glutamyl-glutamic acid Proteins 0.000 abstract 1
- 210000004185 liver Anatomy 0.000 abstract 1
- 108010009298 lysylglutamic acid Proteins 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/002—Protozoa antigens
- A61K39/015—Hemosporidia antigens, e.g. Plasmodium antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/385—Haptens or antigens, bound to carriers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
- A61P33/06—Antimalarials
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/44—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from protozoa
- C07K14/445—Plasmodium
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/20—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans from protozoa
- C07K16/205—Plasmodium
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/60—Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
- A61K2039/6018—Lipids, e.g. in lipopeptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
- Y10S530/82—Proteins from microorganisms
- Y10S530/822—Protozoa
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Tropical Medicine & Parasitology (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Immunology (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Mycology (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Genetics & Genomics (AREA)
- Epidemiology (AREA)
- Microbiology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biophysics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Gastroenterology & Hepatology (AREA)
- Zoology (AREA)
- General Chemical & Material Sciences (AREA)
- Toxicology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Compositions Of Macromolecular Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR9507007A FR2735478B1 (fr) | 1995-06-13 | 1995-06-13 | Molecules polypeptidiques de stade pre-erythrocytaire du paludisme |
Publications (1)
Publication Number | Publication Date |
---|---|
HK1084403A1 true HK1084403A1 (en) | 2006-07-28 |
Family
ID=9479927
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HK06106687.9A HK1084403A1 (en) | 1995-06-13 | 2006-06-12 | Conjugates of malarial pre-erythrocytic stage polypeptide molecules and lipids |
Country Status (13)
Country | Link |
---|---|
US (3) | US6191270B1 (ja) |
EP (2) | EP1621547B1 (ja) |
JP (2) | JPH11508130A (ja) |
AT (2) | ATE302276T1 (ja) |
AU (1) | AU719163B2 (ja) |
CA (1) | CA2221029A1 (ja) |
DE (2) | DE69638127D1 (ja) |
DK (2) | DK0833917T3 (ja) |
ES (1) | ES2248816T3 (ja) |
FR (1) | FR2735478B1 (ja) |
HK (1) | HK1084403A1 (ja) |
PT (1) | PT833917E (ja) |
WO (1) | WO1996041877A2 (ja) |
Families Citing this family (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2672290B1 (fr) * | 1991-02-05 | 1995-04-21 | Pasteur Institut | Sequences peptidiques specifiques des stades hepatiques de p. falciparum porteuses d'epitopes capables de stimuler les lymphocytes t. |
FR2697022B1 (fr) * | 1992-10-19 | 1994-12-16 | Pasteur Institut | Antigènes de Plasmodium falciparum capables d'induire des anticorps protecteurs à large spectre - Application à la vaccination. |
US20030161840A1 (en) * | 1992-10-19 | 2003-08-28 | Institut Pasteur | Plasmodium falciparum antigens inducing protective antibodies |
FR2735478B1 (fr) * | 1995-06-13 | 1997-08-22 | Pasteur Institut | Molecules polypeptidiques de stade pre-erythrocytaire du paludisme |
FR2771640B1 (fr) * | 1997-12-03 | 2000-02-11 | Inst Nat Sante Rech Med | Micelles mixtes de lipopeptides pour l'induction d'une reponse immunitaire et leurs utilisations a des fins therapeutiques |
EP1201250A1 (en) * | 2000-10-25 | 2002-05-02 | SMITHKLINE BEECHAM BIOLOGICALS s.a. | Immunogenic compositions comprising liver stage malarial antigens |
WO2002092628A2 (fr) * | 2001-05-16 | 2002-11-21 | Institut Pasteur | Antigenes de plasmodium falciparum et leurs applications vaccinales et diagnostiques |
DK1350839T3 (da) | 2002-04-05 | 2010-07-12 | Pasteur Institut | Identificering af de virulensassocierede regioner RD1 og RD5, hvilket muliggør udvikling af forbedrede vacciner af M. bovis BCG og M. microti |
JP5116971B2 (ja) * | 2002-10-15 | 2013-01-09 | インターセル アーゲー | B群連鎖球菌の接着因子をコードする核酸、b群連鎖球菌の接着因子、およびその使用 |
KR101035111B1 (ko) * | 2004-06-30 | 2011-05-19 | 주식회사 엘지생명과학 | 말라리아 플라스모듐 팔시파룸의 면역학적 측정방법 및이에 사용되는 측정 수단 |
US8401159B2 (en) * | 2005-11-30 | 2013-03-19 | On-Q Telecom Systems Co., Inc. | Data provision to a virtual personal assistant for handling calls in a communication system |
EP2648744B1 (en) | 2010-12-06 | 2020-06-03 | MalVa GmbH | Malaria vaccines based on pre-erythrocytic antigens from p. falciparum |
CN117069819B (zh) * | 2023-09-13 | 2024-03-19 | 南华大学 | 一种黑腹狼蛛抗菌肽lc-amp-i1及其应用 |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0014815A3 (de) * | 1978-12-20 | 1980-10-29 | Ciba-Geigy Ag | Peptidderivate, Verfahren zu deren Herstellung und Zwischenprodukte sowie pharmazeutische Präparate mit einer dieser Verbindungen |
US6270771B1 (en) * | 1988-10-06 | 2001-08-07 | Institut Pasteur | Peptide sequences specific for the hepatic stages of P. falciparum bearing epitopes capable of stimulating the T lymphocytes |
FR2672290B1 (fr) * | 1991-02-05 | 1995-04-21 | Pasteur Institut | Sequences peptidiques specifiques des stades hepatiques de p. falciparum porteuses d'epitopes capables de stimuler les lymphocytes t. |
FR2679909B1 (fr) * | 1991-07-31 | 1995-08-25 | Pasteur Institut | Polypeptides aptes a induire in vivo des anticorps inhibant l'invasion de globules rouges par des merozouites de p. falciparum, produits apparentes et leur application comme vaccin. |
FR2697022B1 (fr) * | 1992-10-19 | 1994-12-16 | Pasteur Institut | Antigènes de Plasmodium falciparum capables d'induire des anticorps protecteurs à large spectre - Application à la vaccination. |
FR2735478B1 (fr) * | 1995-06-13 | 1997-08-22 | Pasteur Institut | Molecules polypeptidiques de stade pre-erythrocytaire du paludisme |
-
1995
- 1995-06-13 FR FR9507007A patent/FR2735478B1/fr not_active Expired - Fee Related
-
1996
- 1996-06-12 DE DE69638127T patent/DE69638127D1/de not_active Expired - Lifetime
- 1996-06-12 EP EP05016651A patent/EP1621547B1/fr not_active Expired - Lifetime
- 1996-06-12 AU AU63096/96A patent/AU719163B2/en not_active Ceased
- 1996-06-12 ES ES96922107T patent/ES2248816T3/es not_active Expired - Lifetime
- 1996-06-12 CA CA002221029A patent/CA2221029A1/fr not_active Abandoned
- 1996-06-12 DK DK96922107T patent/DK0833917T3/da active
- 1996-06-12 US US08/973,462 patent/US6191270B1/en not_active Expired - Lifetime
- 1996-06-12 PT PT96922107T patent/PT833917E/pt unknown
- 1996-06-12 WO PCT/FR1996/000894 patent/WO1996041877A2/fr active IP Right Grant
- 1996-06-12 EP EP96922107A patent/EP0833917B1/fr not_active Expired - Lifetime
- 1996-06-12 AT AT96922107T patent/ATE302276T1/de not_active IP Right Cessation
- 1996-06-12 DK DK05016651.1T patent/DK1621547T3/da active
- 1996-06-12 DE DE69635077T patent/DE69635077T2/de not_active Expired - Lifetime
- 1996-06-12 JP JP9502711A patent/JPH11508130A/ja active Pending
- 1996-06-12 AT AT05016651T patent/ATE458002T1/de not_active IP Right Cessation
-
2000
- 2000-12-22 US US09/742,096 patent/US7056518B2/en not_active Expired - Fee Related
-
2005
- 2005-08-04 US US11/196,400 patent/US20050287166A1/en not_active Abandoned
-
2006
- 2006-06-12 HK HK06106687.9A patent/HK1084403A1/xx not_active IP Right Cessation
-
2008
- 2008-05-28 JP JP2008139896A patent/JP2009000104A/ja not_active Withdrawn
Also Published As
Publication number | Publication date |
---|---|
CA2221029A1 (fr) | 1996-12-27 |
US6191270B1 (en) | 2001-02-20 |
AU719163B2 (en) | 2000-05-04 |
DK1621547T3 (da) | 2010-06-07 |
AU6309696A (en) | 1997-01-09 |
DE69638127D1 (de) | 2010-04-01 |
FR2735478B1 (fr) | 1997-08-22 |
US20020155441A1 (en) | 2002-10-24 |
EP0833917B1 (fr) | 2005-08-17 |
ATE302276T1 (de) | 2005-09-15 |
US7056518B2 (en) | 2006-06-06 |
WO1996041877A3 (fr) | 1997-01-23 |
DK0833917T3 (da) | 2005-12-05 |
ATE458002T1 (de) | 2010-03-15 |
PT833917E (pt) | 2005-11-30 |
US20050287166A1 (en) | 2005-12-29 |
ES2248816T3 (es) | 2006-03-16 |
JP2009000104A (ja) | 2009-01-08 |
EP1621547B1 (fr) | 2010-02-17 |
DE69635077T2 (de) | 2006-05-18 |
JPH11508130A (ja) | 1999-07-21 |
DE69635077D1 (de) | 2005-09-22 |
EP1621547A1 (fr) | 2006-02-01 |
WO1996041877A2 (fr) | 1996-12-27 |
FR2735478A1 (fr) | 1996-12-20 |
EP0833917A2 (fr) | 1998-04-08 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HK1084403A1 (en) | Conjugates of malarial pre-erythrocytic stage polypeptide molecules and lipids | |
AU629649B2 (en) | Novel procoagulant proteins | |
NZ330897A (en) | Human trk receptors and neurotropic factor inhibitors | |
ATE86636T1 (de) | F antigene vom menschlichen immunodefizienz-virus und deren verwendungen. | |
NZ503007A (en) | Conjugates that contain the homeodomain of antennapedia | |
EP0875567A3 (de) | Myc-bindende Zinkfinger-Proteine, ihre Herstellung und ihre Verwendung | |
CA2249180A1 (en) | Methods for recombinant microbial production of bpi-fusion proteins and bpi-derived peptides | |
EP0330878A3 (en) | Anti-ras protein-antibodies | |
WO1999002708A8 (en) | Fusion proteins comprising sequences derived from bovine if1 atpase inhibitor protein | |
WO1996002572A3 (fr) | Sequence polypeptidique antigenique du facteur viii, fragments et/ou epitopes de celle-ci | |
AU1444699A (en) | Single-chain polypeptides comprising troponin i and troponin | |
WO1999033989A3 (en) | Rantes mutants and therapeutic applications thereof | |
ATE224403T1 (de) | Verwendung von kaseinfragmenten als wachstumerförderer | |
CA2163805A1 (en) | Novel activating factor of leukocytes | |
PL347943A1 (en) | Moraxella catarrhalis basb034 polypeptides and uses thereof | |
CA2083286A1 (en) | Recombinant fibrinogenases, preparation and use thereof | |
EP0290029A3 (en) | (19-alanine) calcitonin | |
Bolen et al. | Cytotoxic protein from the yeast Pichia inositovora | |
Allen | Protein V: A IgG binding factor. | |
IT1261676B (it) | Proteine ricombinanti, vettori per l'espressione e loro usi. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PC | Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee) |
Effective date: 20130612 |